CD45 is a protein tyrosine phosphatase involved in T and B cell signaling. While peripheral T cells switch CD45 isoforms upon activation, events leading to exon switching during T cell development in the thymus have not been determined. The expression of high molecular weight isoforms of CD45 was examined on thymocytes from nontransgenic and T cell receptor (TCR) transgenic mice. All thymocytes from nontransgenic mice were CD45RB* as assessed by staining with MB23G2, an anti-CD45RB-specific monoclonal antibody. Interestingly, there was a small population (1-3%) of thymocytes that displayed a higher intensity of staining with MB23G2, CD45RBh~g h. CD45RBhis h thymocytes were found in all subsets defined by CD4 and CD8 expression and were also present within the TCR-odBhis h population. To analyze whether or not CD45 expression correlated with thymic selection events, expression of CD45tLB high and a second isoform, CD45RA, was examined on thymocytes from H-Y and 2C TCR transgenic mice and found to correlate with positive and negative selection events but did not occur in nonselecting backgrounds. CD45RA and CD45RBhlg h upregulation was also not observed in transgenic mice backcrossed into CD8-deficient mice, a scenario in which there is no positive selection of transgene-expressing thymocytes. These data suggest that modulation of CD45 isoform expression may be involved in thymic selection events.
CD45 is a protein tyrosine phosphatase involved in T and B cell signaling. While peripheral T cells switch CD45 isoforms upon activation, events leading to exon switching during T cell development in the thymus have not been determined. The expression of high molecular weight isoforms of CD45 was examined on thymocytes from nontransgenic and T cell receptor (TCR) transgenic mice. All thymocytes from nontransgenic mice were CD45RB* as assessed by staining with MB23G2, an anti-CD45RB-specific monoclonal antibody. Interestingly, there was a small population (1-3%) of thymocytes that displayed a higher intensity of staining with MB23G2, CD45RBh~g h. CD45RBhis h thymocytes were found in all subsets defined by CD4 and CD8 expression and were also present within the TCR-odBhis h population. To analyze whether or not CD45 expression correlated with thymic selection events, expression of CD45tLB high and a second isoform, CD45RA, was examined on thymocytes from H-Y and 2C TCR transgenic mice and found to correlate with positive and negative selection events but did not occur in nonselecting backgrounds. CD45RA and CD45RBhlg h upregulation was also not observed in transgenic mice backcrossed into CD8-deficient mice, a scenario in which there is no positive selection of transgene-expressing thymocytes. These data suggest that modulation of CD45 isoform expression may be involved in thymic selection events.
C
D45 is a glycosylated transmembrane protein tyrosine phosphatase expressed on all hemopoietic cells except erythrocytes and platelets (reviewed in reference 1). Multiple isoforms of CD45 are generated through differential splicing of extracellular domain exons 4, 5, 6, and 7 (1, 2). The low molecular weight isoform of CD45, which lacks exons 4-6, is referred to as CD45RO; however, in the routine system there are no antibodies available that detect this isoform (1) . CD45 isoforms reactive with anti-exon 4-, 5-, and 6-spedfic mAbs are referred to as CD45RA, CD45RB, and CD45RC, respectively (1) . In both human and murine systems, differential isoform expression is cell type, differentiation, and activation stage specific (1) . Cell surface expression of CD45 is required for antigen receptor-mediated signaling in T and B cells (3) (4) (5) . A B cell surface molecule, CD22, has been reported to bind the lowest molecular weight isoform of human CD45, CD45RO (6) . However, the functions and ligands for other CD45 isoforms still remain speculative.
T cells mature in the thymus, where they are subjected to selection processes resulting in the production of a peripheral T cell pool that is restricted to self-MHC molecules but is self-tolerant (7). Studies with TCR V/g-specific antibodies and TCR transgenic mice have provided direct evidence for tolerance induction by clonal deletion of T cells reactive against self-antigens and positive selection of TCR-odB by MHC molecules (7) (8) (9) . The results of these and other studies have established a model of thymic differentiation in which TCR/CD3-CD4-CDS-(double-negative; DN 1) thymocyte precursors give rise to immature CD4 + CD8 + (doublepositive; DP) thymocytes expressing low levels of TCR/ CD3. Thymocytes that are positively selected through TCR interaction with self-MHC mature into CD4 § -or CD4-CD8 + single-positive (SP) cells expressing high levels of TCR/CD3 (9, 10). Positive and negative selection most likely involves signaling through the TCR. However, the molecular events associated with these signals are not well understood. Activation of peripheral T cells induces changes in alternative splicing of the CD45 mRNA, which result in changes of CD45 isoform expression at the cell surface (11) . However, it is not known if signaling through the TCR during thymic development can also induce changes in CD45 isoform expression. Thus, CD45 isoform expression was examined on thymocytes from nontransgenic and TCR transgenic animals. Previous studies have indicated that the majority of immature murine thymocytes express low molecular weight CD45 on the call surface (12) . In contrast, mature CD4 SP and CD8 SP thymocytes were shown to express larger molecular weight CD45 glycoproteins, suggesting that there is a molecular switch in regulation of CD45 protein expression upon maturation of thymocytes to the SP lineage (12) . We present evidence that the majority of thymocytes are also CD45RB + when stained with MB23G2, an anti-CD45RB-specifc mAb (13) . Two populations of CD45RB + thymocytes were observed, CD45RB t~ and a small population (1-3%) with CD45RBhg h expression. CD45RBhig h thymocytes were present in all four subsets defined by CD4 and CD8 expression and in a population of TCR-~/~ h~gh thymocytes. Expression of CD45RB high and CD45RA on TCR transgene-positive thymocytes from two different TCR transgenie mouse models was also investigated. Expression of CD45RBh'g h and CD45RA on transgene-positive thymocytes was found to correlate with selection events. These results suggest that modulation of CD45 isoform expression may be involved in thymic selection events.
Materials and Methods
Mice. 6-wk-old female BALB/c, B10.BR., C57BL/6, and DBA/2 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). CDS-deficient mice, and H-Y and 2C transgenic lines, have been described (9, 14, 15) and were bred in our own facilities. H-Y and 2C transgenic mice expressing H-2 b (from C57BL/6), H-2 d (from BALB/c), and H-2 ~ (from B10.BR) with and without the CD8 mutation were generated.
Antibodies and lramunofluorescence. The following mAb's were used: MB23G2 (rat IgG, anti-CD45RB) (13), MB4B4 (rat IgG, anti-CD45RB) (16), 14.8 (rat IgG, anti-CD45RA) (17) , all obtained from American Type Culture CoUection (RockviUe, MD). Biotinylated C363.16A (rat IgG, anti-CD45RB) (18) was obtained from Pharmingen (San Diego, CA). Transgenic TCR expression was detected with the following biotinylated mAbs: T3.70, mAb specific for the c~ chain of the H-Y-specific TCK (9); and 1B2, an anticlonotypic mAb specific for the TCR in 2C transgenic mice (19) (generous gifts from Drs. H.-S. Teh, University of British Columbia, and D. Loh, Washington University, respectively). The following conjugated antibodies were used: CDS-FITC, CD8-biotin, CD4-PE (Becton Dickinson & Co., Mountain View, CA), CD4-FITC, TCR-cff/~-FITC (Pharmingen). For double and triple staining, thymocyte suspensions were first incubated with the appropriate anti-CD45 culture supernatant followed by goat anti-rat IgG-PE or goat anti-rat FITC (Southern Biotechnology Associates, Birmingham, AL). Unbound anti-rat Ig sites were blocked with 1/zg of rat IgG (Sigma Chemical Co., St. Louis, MO). Samples were then double or triple stained with the appropriate conjugated or biotinylated mAbs. Staining of biotinylated antibodies was developed with streptavidin-Texas red (Gibco Laboratories, Grand Island, NY). As a control for background fluorescence, samples were incubated with second-stage goat anti-rat-conjugated reagents followed by staining with the appropriate anti-TCR mAb. Samples were run on a FACScan | (Becton Dickinson & Co.). Data from viable cells were collected using a live gate by a combination of forward and 90 ~ light scatter, and 18,000 live gated events were collected. CD45RA and CD45RB expression on transgenic thymocytes was determined in two (H-Y transgenic mice) and three (2C transgenic mice) independent experiments. Representative values from one experiment are shown in Figs. 2, 3, and 4.
Results

CD45RB Expression on Thymocytes.
Thymocytes from C57BL/6, BALB/c, and DBA/2 mice were stained for CD45RB expression using the CD45 exon 5-specific mAb MB23G2. All thymocytes were found to be CD45RB + ( Fig. 1) , which is in contrast to previous reports suggesting that the majority of immature thymocytes express the lowest molecular weight isoform of CD45, which lacks exons 4, 5, and 6 (12). Moreover, there was a small population (1-3%) of thymocytes that had a higher intensity of CD45RB staining, hereafter referred to as CD45RB high ( Fig. 1 ). Repeated analysis yielded consistent results. Triple staining for CD45RB, CD4, and CD8 expression on thymocytes revealed that CD45R.Bhg h cells were present in all thymic CD4/CD8 subsets and were enriched in the DN and CD8 SP populations (Table 1 ). CD45RBhg h cells were also present on a population of TCR-o~/~/h* h thymocytes (Fig. 1) . Similar results were obtained with two other CD45RB-specific antibodies, C363.16A and MB4B4 (16, 18 , data not shown).
The observation that CD45RB high expression was most apparent among TCR.-o~/~ high thymocytes suggested that expression of CD45R.B high might be a marker associated with the maturation of this subset. TCK transgenic mice provide a good model system in which to test this hypothesis since the differentiation of transgenic thymocytes can be followed with mAbs specific for the transgenic TCK. Therefore, thymocytes from two TCK transgenic models, H-Y and 2C, were analyzed for CD45RB, CD45RA, and transgene expression in positive, neutral (nonsdecting), and negative selection backgrounds.
CD45RA and CD45RBhia h Expression on H-Y ~ansgenic Thymocytes.
The H-Y transgenic TCK is specific for the male H-Y antigen in the context of H-2 D b. Positive sdection of this transgenic TCK in female H-2 b/b mice is characterized by transgene expression, detected with the mAb T3.70 spedfic for the transgenic c~ chain, on mature CD8 SP thymocytes (9) . When the transgene is expressed in a nonsdecting background, H-2 d/a, thymocytes expressing T3.70 are blocked at the DP immature stage of development (9) . Although there is a small population of thymocytes in H-2 a/d mice that express high levels of the transgenic receptor, it has been established that these cells are DN thymocytes (9) . CD45KA, CD45R.Bhg h, and T3.70 expression was examined on thymocytes from female H-2 b/b and H-2 a/a transgenic mice. CD45KA and CD45RB hgh expression was observed in a population of T3.70 hgh ceils in H-2 b/b mice but not in (9, 20) . Therefore, in H-2 b/b mice, the majority (>70%) of thymocytes with CD45RA and CD45RBhig h expression have been positively selected. It should be noted that of the total T3.70 high CD8 SP population, only 56% were CD45RA + and 52% CD45R.Bhig h. Sdection of the H-Y TCR is dependent upon CD8 expression since this TCR cannot be selected when the transgene is backcrossed into mice deficient for CD8 expression (CD8 -/-) (15, 20a) . T3.70 + thymocytes from CD8 -/-female H-2 b/b transgenic mice did not express CD45RA or CD45RBhig h (data not shown). Therefore, the development of T3.70 + thyrnocytes expressing CD45RA or CD45RB~g h is dependent upon positive selection of the transgenic TCR and was not observed in either of two instances in which there was a lack of positive selection: absence of H-2 D b expression or deficient CD8 expression. CD45RA and CD45RB~s h expression was also examined on T3.70 + thymocytes developing in the presence of the deleting H-Y antigen in male H-2 b/b transgenic mice. Negative selection in male H-Y mice results in a drastic reduction of DP thymocytes (9) . The remaining T3.70 + CD8 SP thymocytes display a CD8 ]~ phenotype, and it has been suggested that they represent cells that have escaped negative selection by downregulating CD8 surface expression (9, 21) . In male transgenic mice there were populations of CD45KA + T3.70 § and CD45RBhig h T3.70 § thymocytes (Fig. 2) . Triple staining revealed that CD45RA § T3.70 § thymocytes belonged to the CD8 k'w (16%), DN (78%), and the DP (6%) subsets. Similarly, CD45RB hish T3.70 + thymocytes belonged to CD8 ~w (15%), DN (81%), and DP (4%) subsets. Since the development of the T3.70 + CD8 l~ subset is dependent upon the presence of H-Y/H-2 D b (22), CD45RA and CD45RBh~s h expression was occurring on a selected subset of transgene-positive thymocytes. Within the T3.70 § CD8 l~ subset, only 50% and 43% of thymocytes were CD45RA § and CD45RBhis h, respectively.
Negative selection of the H-Y TCK in male mice is dependent upon CD8 expression since efficient deletion of transgenic thymocytes did not occur in CD8 -/-male transgenic mice (20a). CD45RA expression was not observed on thymocytes from CD8-/-male mice, however, CD45RB~ h expression on T3.70 + cells was detected (data not shown).
CD45RA and CD45RBhi~ h Expression on 2C Transgenic
Thymocytes. CD45RA and CD45RB ~sh expression on thymocytes from H-Y mice correlated with selection events. To confirm these resuhs, thymocytes from 2C TCK transgenic mice were stained for CD45RA, CD45R.B high, and transgene expression. The 2C transgenic TCR, detected with the anticlonotypic mAb 1B2, is alloreactive against H-2 L a (19) . Maturation of 1B2 § T cells to the CD8 SP compartment requires the presence of the H-2 K b molecule (23, 24) . Thymocytes from 2C transgenic mice backcrossed into a nonselecting background, H-2 k/k, are blocked at the immature DP stage of development (23) . In nonsdecting mice, 1B2~s h thymocytes belong to the DN compartment (25) . As shown in Fig. 3 , there are populations of CD45RA + 1B2hig h and CD45RB~s h 1B2hJs h thymocytes present in H-2 b/h mice that are absent in nonselecting H-2 k/k mice. Triple staining revealed that CD45RA + 1B2 high thymocytes from H-2 b/b mice were CD8 SP (82%), DP (10%), and DN (8%). CD45R.Bhig h 1B2his h thymocytes were found among CD8 SP (70%), DP (16%), and DN (12%) thymocyte subsets. Within the 1B2 + CD8 SP mature subset in H-2 b/b mice, only 20% of thymocytes expressed CD45RA or CD45R.B high.
CD45RA + 1132 hish thymocytes were also not observed in nonselecting CD8-/-H-2 b/b 2C transgenic mice ( Fig. 4;  20a) . Therefore, the appearance of transgene-positive thymocytes in 2C transgenic mice expressing CD45RA and CD45R.B high was dependent upon sdection since these populations were not observed when positive selection did not occur due to the absence of H-2 K b or CD8 expression.
In Fig. 3, top left, there is also a population of CD45RA § 1B2-thymocytes (1.0%) with higher intensity CD45RA expression than CD45KA + 1B2~s h thymocytes. These cells were identified as B cells by their IgM +, Thy-1-, and TCRor//3-surface phenotype (data not shown).
Negative selection of the 2C TCR occurs in the presence of H-2 L d molecules and is characterized by deletion of DP thymocytes (23) . As shown in Fig. 3, CD45RA and CD45KBhis h expression are upregulated on 1B2 + thymocytes in 2C H-2 d/b mice. However, CD45RA + and CD45RBhig h cells in H-2 b/a mice have a lower 1B2 intensity than CD45KA + and CD45RBhig h cells in positively selecting H-2 b/b mice (Fig. 3) . Triple staining with anti-CD45, 1B2, and either CD4 or CD8 revealed that these cells were DN (99%) and DP (1%). Deletion of 1B2 + cells is not dependent on CD8 expression since negative selection of this TCR still occurs in CD8 ,,~ Figure 4 . CD45RA expression on 2C transgenic thymocytes in CD8 +/+ and CD8 -/-mice. Thymocytes were stained with anti-CD45RA antibodies and 1B2 as described in Fig. 3 . Shown is CD45RA vs. 1B2 expression on thymocytes from CD8 +/+ and CD8 -/-mice in H-2 b/b and H-2 d/b haplotypes. Percentages of CD45RA § thymocytes were determined as described in Materials and Methods. Quadrant markers were set as described in Fig. 3 . The mice in this analysis were 11-15 wk of age.
CD8-/-transgenic animals was still observed (Fig. 4 ). In the thymus of H-2 b/a mice there was also a population of 1B2-ceils with high-intensity CD45RA expression that were identified as B cells by their IgM + and Thy-l.2-phenotype ( Fig. 3 ; and data not shown).
Discussion
CD45R.B expression was examined on thymocytes from normal mice. While all thymocytes were CD45tLB +, there was a small population (1-3%) with a higher intensity of CD45P,.B expression (CD45R.Bhigh). CD45R.B high thymocytes, while present in all four thymic subsets defined by CD4 and CD8 expression, were predominant in the DN and CD8 SP subsets. Skewing towards the DN and CD8 SP subsets of expression of high molecular weight isoforms of CD45 has also been reported for CD45RA, CD45RC, and CD45P,.B (26) (27) (28) . Double staining with CD45P, B and TCR-od3-specific antibodies revealed a population of CD45R.B high TCR-ce/3hig h thymocytes. CD45RA antibodies have also been shown to stain a small population of TCR/CD3his h thymocytes (27) . However, in contrast to our findings, CD45RBhig h staining was found on a population of thymocytes with an intermediate intensity of TCR-od3 expression (28) .
Expression of CD45RA and CD45RB isoforms was also examined on thymocytes from H-Y and 2C TCR transgenic mice in selecting (H-2b/b), nonselecting (H-2 a/d for H-Y and H-2 k/k for 2C), and deleting (H-2 b/b male mice for H-Y and H-2 b/d for 2C) backgrounds. It has been proposed that thymocytes expressing high molecular weight isoforms of CD45 represent a thymic generative lineage that maintains CD45RA expression throughout intrathymic differentiation (29) . The observation that CD45RA + and CD45RB high TCR + thymocytes were present among the DN, DP, and CD8 SP subsets in both transgenic models in positive selecting backgrounds may support this continuous lineage model whereby CD45RA and CD45RB high are expressed during thymic development. However, in nonselecting backgrounds of the two different transgenic mouse models, DN and DP CD45RA + and CD45R.B hiSh thymocytes expressing high levels of the transgenic TCR were absent from both TCR transgenic mice, a finding that is in conflict with this model.
Our observations are consistent with an alternative model in which expression of CD45RA and CD45R.Bhig h is induced by thymic maturation events. In both H-Y and 2C TCR transgenic models studied here, expression of CD45KA and CD45RB high on transgene-positive thymocytes occurred only when the ligands for positive or negative selection were present. In the H-2b/b-sdecting haplotype, CD45RA and CD45RBhig h expression on T3.70his h thymocytes from female H-Y mice was observed on a subset of TCKhig h CD8 SP and DP thymocytes, both of which are positively selected populations (9, 20) Not all mature calls in a normal thymus are positive for CD45RA and CD45RBhis h expression. Similarly, not all mature transgenic TCR + CD8 SP thymocytes in either transgenic model are positive for CD45RA and CD45RB~g h expression, although they express identical TCKs. One possibility is that CD45RA and CD45RBh~g h expression could be a transient event during development, perhaps occurring upon maturation from DP to mature SP thymocytes populations. The increase in the number of CD45RA + or CD45RB high ceils among transgenic thymocytes as compared with nontransgenic thymocytes may be due to the fact that in transgenic mice more thymocytes have been positively selected at any given time. This is supported by the observation that there are more CD8 SP and DP TCR high thymocytes in transgenic as compared with nontransgenic mice (9, 23, 30) .
CD45RA and CD45RB high expression was also found on TCR. high DN thymocytes in H-2 b/b HoY and 2C transgenic mice. The presence of transgenic TCR. high DN thymocytes has been reported in both transgenic models and their development is not dependent upon positive selection (9, 25) . The observation that an interaction of CD8 with H-2 D b is required for positive selection of the H-Y TCR + cells (31) and that CD8 expression is required for positive selection of both H-Y and 2C TCR-bearing thymocytes (20a) renders it unlikely that CD45RA +-and CD45RBhigh-expressing TCPx high DN thymocytes detected in H-2 b/b transgenic mice are the products of positive selection. An alternative hypothesis is that these cells may be thymic progenitor cells that express the transgenic TCR at an early stage, since in both rat and mouse thymic precursor activity can be detected within a population of DN thymocytes expressing high molecular weight CD45 (32, 33) . This is also supported by data that in both transgenic models the transgene is expressed very early in development on DN thymocytes (25, 34) .
In 2C H-2b/d-ddeting transgenic mice, 1B2 high thymocytes expressing CD45RA and CD45R.B high were found almost exclusively within the DN subset. The observation that there were more 1B2 + DN thymocytes expressing CD45RA and The differences in CD45RA and CD45R.B high expression on thymocytes described in this report may be due to differential binding of the exon-specific mAbs as a result of conformational or glycosylation changes in the CD45 molecules during thymic development rather than differences in exon usage. However, the epitopes detected by the CD45 exon-specific mAbs used in these experiments are not dependent upon lymphocyte-specific glycosylation since they have been shown to stain CD45-transfected fibroblast lines and are not disrupted by the presence of other variable exons (16, 35; and V. A. Wallace, unpublished observations). While these results do not completely rule out that the antibodies recognize a glycosylated epitope, or that glycosylation on other exons may affect epitope recognition, the differential staining of thymocytes that we observe with these antibodies clearly correlates with selection events.
In conclusion, the data from normal thymocytes and from the transgenic mouse models suggest that thymic selection events may induce expression of CD45 isoforms containing variable exons. However, activation of peripheral T cells expressing high molecular weight CD45 isoforms results in exon switching to low molecular weight isoforms (11) . This difference may arise because the molecular events associated with peripheral T cell activation may be different from those initiated during thymic selection. Alternatively, the goal of thymic selection is to produce naive T calls expressing high molecular weight CD45 (36) . The functional implications of selection-induced upregulation of CD45 high molecular weight isoforms on thymocyte signaling and development need to be determined.
